Abstract: Provided herein are methods of making, amplifying, and sequencing tagged nucleic acid complements, compositions including interposing oligonucleotide barcodes, and kits useful in obtaining long-range sequence data.
Type:
Grant
Filed:
September 27, 2021
Date of Patent:
November 12, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Eli N. Glezer, Martin Maria Fabani, Ryan Shultzaberger, Bharat Sridhar, Gudrun Stengel, Christopher Jen-Yue Wei
Abstract: Provided herein are methods including alternating series of sequencing cycles and dark extension cycles allowing longer read lengths and addressing disadvantages of traditional nucleic acid sequencing protocols.
Type:
Grant
Filed:
December 8, 2021
Date of Patent:
October 22, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Eli N. Glezer, Abrehet Abdu, Timothy Looney
Abstract: Provided herein are methods for sequencing both strands of a double stranded nucleic acid fragment that improves fidelity and accuracy of a sequence determination compared to traditional next generation sequencing methods. Compositions and kits for use in the methods are also provided.
Type:
Grant
Filed:
April 22, 2022
Date of Patent:
October 22, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Eli N. Glezer, Martin Maria Fabani, Timothy Looney, Sabrina Shore, Ryan Shultzaberger, Daan Witters
Abstract: Provided herein are modified Archaeal family B polymerases derived from the Archaeal microorganism Thermococcus sp. EP1 that exhibit improved incorporation of nucleotide analogues utilized in DNA sequences.
Type:
Grant
Filed:
October 20, 2022
Date of Patent:
October 8, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Souad Naji, Carl W. Fuller, Eli N. Glezer, Andrew Spaventa
Abstract: Provided herein are methods for sequencing both strands of a double stranded nucleic acid fragment that improves fidelity and accuracy of a sequence determination compared to traditional next generation sequencing methods. Compositions and kits for use in the methods are also provided.
Type:
Grant
Filed:
October 13, 2021
Date of Patent:
September 3, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Eli N. Glezer, Martin Maria Fabani, Sabrina Shore, Daan Witters
Abstract: Disclosed herein, inter alia, are compositions and methods for amplification of nucleic acid templates, including hybridizing a linear polynucleotide to an immobilized primer on a surface, circularizing the linear polynucleotide to form a circular polynucleotide, and extending the primer with a polymerase.
Type:
Grant
Filed:
March 1, 2023
Date of Patent:
August 27, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Daan Witters, Eli N. Glezer, Andrew King, Sabrina Shore, Ryan Shultzaberger
Abstract: The present disclosure relates to a flow cell carrier. The flow cell carrier may include a flow cell and a frame. The frame may include a pocket and a handle. The pocket may have at least one spring feature and at least one banking feature. The frame may be configured to retain the flow cell within the pocket such that a maximal surface area of the flow cell is exposed to an optical lens. Related methods and kits are also disclosed.
Type:
Grant
Filed:
July 18, 2023
Date of Patent:
August 20, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Sandor Kovacs, Anson Hsu, David Baranson, John Van Doorn, Eli N. Glezer
Abstract: Provided herein are methods and compositions for improved sequencing techniques using, for example, polymeric particles and/or three-dimensional structures.
Type:
Grant
Filed:
December 3, 2021
Date of Patent:
August 13, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Eli N. Glezer, Mohammad Vatankhah Varnosfaderani, Daan Witters, Vahid Karimkhani
Abstract: Disclosed herein, inter alia, are silicon containing detectable compounds and methods of use thereof. In an aspect is provided a monovalent nucleotide or monovalent nucleoside covalently bound to a monovalent form of a compound described herein (e.g., wherein the R13 moiety of a compound described herein has reacted with a bioconjugate reactive group to form a bioconjugate linker thereby covalently bonding the monovalent compound to the monovalent nucleotide or monovalent nucleoside).
Type:
Grant
Filed:
August 5, 2022
Date of Patent:
May 21, 2024
Assignee:
Singular Genomics Systems, Inc.
Inventors:
Megha Cila, Ronald Graham, Rodrigo Rodriguez
Abstract: A connector assembly is configured to fluidly and removably connect a first set of microtubes to a second set of microtubes of a microfluidic device. The connector assembly provides multiple points of contact to the microtubes to provide a secure connection between the connector assembly and the microtubes. A single gasket provides a securely aligned connection between microtubes.